Quanta Announces Pricing and Terms for Cash Capital Increase and Issuance of Overseas Depository Receipts

1. Factual Date: 115/07/30 2. Company Name: Quanta 3. Relationship with Company (Please enter '本公司' or 'Subsidiary'):本公司 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: Completion of pricing and issuance terms for the company's cash capital increase through the issuance of ordinary shares and participation in the issuance of overseas depository receipts 6. Countermeasures: None 7. Other Matters to be Disclosed (If the subject of the event or resolution is a publicly issued company or above, this significant information also meets the criteria under Article 7, Paragraph 9 of the Enforcement Rules of the Securities and Exchange Act, regarding matters having a significant impact on shareholder rights or securities prices):

I. Issuance Terms for the Company's Cash Capital Increase and Ordinary Share Issuance Participating in the Issuance of Overseas Depository Receipts: (1) Total Issuance Amount: USD 2,164,330,000. (2) Unit Issuance Price: USD 44.17 per unit. (3) Total Number of Units Issued: 49,000,000 units of overseas depository receipts issued, representing 245,000,000 ordinary shares. (4) Pricing Date: 115/07/29 (5) Scheduled Issuance Date: 115/08/03 (6) Number of Shares Represented per Unit of Overseas Depository Receipt: 1 unit of overseas depository receipt represents 5 ordinary shares of the company. (7) Price per Share: Approximately NT$287.06 (converted at an exchange rate of USD 1 = NT$32.495)

II. Issuance and Trading Location: Luxembourg Stock Exchange

III. Circumstances Regarding Subscription by Specific Parties: None.

IV. Fund Utilization Plan and Expected Benefits: The proceeds from this fundraising will be used to meet foreign currency material procurement funding needs.

V. Main Impact on Shareholder Rights: This cash capital increase involves the issuance of 245,000,000 ordinary shares to participate in the issuance of overseas depository receipts, resulting in an equity dilution ratio of approximately 5.97%, which will not cause significant dilution to shareholder rights.